Tao Feng
Chairman bij Shenzhen Fer Capital Investment Co. Ltd.
Profiel
Tao Feng is currently the Chairman of Shenzhen Fer Capital Investment Co. Ltd., Director of Beijing Kangpusen Biotechnology Co. Ltd., and Director of Beijing Microread Genetics Co., Ltd.
Prior to his current positions, he served as the President of Walvax Biotechnology Co., Ltd.
from 2007 to 2012 and as a Non-Executive Director of Jiangsu Recbio Technology Co., Ltd.
from 2020 to 2023.
Dr. Feng holds a doctorate degree from both the Université de Versailles Saint-Quentin-en-Yvelines and the Institute of Advanced Economic & Social Studies.
Actieve functies van Tao Feng
Bedrijven | Functie | Begin |
---|---|---|
Shenzhen Fer Capital Investment Co. Ltd. | Chairman | - |
Beijing Microread Genetics Co., Ltd.
Beijing Microread Genetics Co., Ltd. Medical SpecialtiesHealth Technology Beijing Microread Genetics Co., Ltd. was founded in 2009 and develops test reagents for clinical, forensic, agricultural, animal husbandry, and research fields. The company is based in Beijing, China. | Director/Board Member | - |
Beijing Kangpusen Biotechnology Co. Ltd.
Beijing Kangpusen Biotechnology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Kangpusen Biotechnology Co. Ltd. is a national high-tech enterprise founded in 2011, located in Beijing, China. The Chinese company provides consultation services for genome resources protection and evaluation, gene library construction, genetic diversity evaluation, GWAS analysis, genetic map construction, and QTL positioning. The company also offers agricultural design and breeding services, whole genome select breeding, animal and plant correction, and genetically modified breeding. The company has two major testing centers covering an area of 5,000 square meters and has introduced international leading technology platforms. The company has established advanced research and development departments and have cooperated with industry experts to provide technical guidance and support. | Director/Board Member | - |
Eerdere bekende functies van Tao Feng
Bedrijven | Functie | Einde |
---|---|---|
JIANGSU RECBIO TECHNOLOGY CO., LTD. | Director/Board Member | 03-04-2023 |
WALVAX BIOTECHNOLOGY CO., LTD. | President | 01-01-2012 |
Opleiding van Tao Feng
Université de Versailles Saint-Quentin-en-Yvelines | Doctorate Degree |
Institute of Advanced Economic & Social Studies | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
JIANGSU RECBIO TECHNOLOGY CO., LTD. | Commercial Services |
Bedrijven in privébezit | 3 |
---|---|
Beijing Kangpusen Biotechnology Co. Ltd.
Beijing Kangpusen Biotechnology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Kangpusen Biotechnology Co. Ltd. is a national high-tech enterprise founded in 2011, located in Beijing, China. The Chinese company provides consultation services for genome resources protection and evaluation, gene library construction, genetic diversity evaluation, GWAS analysis, genetic map construction, and QTL positioning. The company also offers agricultural design and breeding services, whole genome select breeding, animal and plant correction, and genetically modified breeding. The company has two major testing centers covering an area of 5,000 square meters and has introduced international leading technology platforms. The company has established advanced research and development departments and have cooperated with industry experts to provide technical guidance and support. | Commercial Services |
Beijing Microread Genetics Co., Ltd.
Beijing Microread Genetics Co., Ltd. Medical SpecialtiesHealth Technology Beijing Microread Genetics Co., Ltd. was founded in 2009 and develops test reagents for clinical, forensic, agricultural, animal husbandry, and research fields. The company is based in Beijing, China. | Health Technology |
Shenzhen Fer Capital Investment Co. Ltd. |